Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylasetissue plasminogen activator-mediated thrombolysis

Nature Medicine

Volumn 1, Issue 3, 1995, Pages 260-266

  Gerhäuser, Clarissa ^a   Mar, Woongchon ^a,b   Lee, Sang Kook ^a   Suh, Nanjoo ^a   Luo, Yingde ^a   Kosmeder, Jerome ^c   Luyengi, Lumonadio ^a   Fong, Harry H S ^a   Kinghorn, A Douglas ^a   Moriarty, Robert M ^c   Mehta, Rajendra G ^a,d   Constantinou, Andreas ^d   Moon, Richard C ^d   Pezzuto, John M ^a,d  

^a Tumor Microenvironment Global Core Research Center   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEGUELIN; ORNITHINE DECARBOXYLASE; RETINOIC ACID; TEPHROSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; LEGUME; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HL-60 CELLS; HUMAN; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; ORGAN CULTURE; ORNITHINE DECARBOXYLASE; PRECANCEROUS CONDITIONS; PROTEIN KINASE C; RNA, MESSENGER; ROTENONE; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE;

EID: 84993915009     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0395-260     Document Type: Article

References (35)

1. Sporn, M.B. & Newton, D.L. Chemoprevention of cancer with retinoids. Fed. Proc. 38, 2528-2534 (1979).
2. Wattenberg, L.W. Chemoprevention of cancer. Cancer Res. 45, 1-8 (1985).
3. Talaly, P. The role of enzyme induction in protection against carcinogenesis. Cancer Chemoprevention (Wattenberg, Lipkin, Boone & Kelloff eds.) 469-478 (CRC Press, Boca Raton, FL, 1992).
4. Kelloff, G.J. et al. Chemopreventive drug development: Perspectives and progress. Cancer Epidemiol. Biomarkers & Prev. 3, 85-98 (1994).
5. Szarka, C.E., Grana, G. & Engstrom, P. Chemoprevention of cancer. Curr. Probl. Cancer 18, 1-78 (1994).
6. Boutwell, R.K. Biochemical mechanism of tumour promotion. Carcinogenesis, Vol. 2. Mechanism of Tumour Promotion and Cocarcinogenesis (Slaga, Sivak & Boutwell, eds.) 49-58 (Raven Press, New York, 1978).
7. Pezzuto, J.M. Cancer chemopreventive agents: from plant materials to clinical trials. Human Medical Agents from Plants (ACS Symposium Series No. 534) (Kinghorn & Balandrin, eds.) 205-217 (American Chemical Society Books, Washington, DC, 1993).
8. Pezzuto, J.M. Natural products cancer chemopreventive agents. Recent Adv. Phytochem. 29 (in the press).
9. Peña, A. et al. Regulation of human ornithine decarboxylase expression by the c-Myc Max protein complex. J. biol. Chem. 268, 27277-27285 (1993).
10. McCann, P.P. & Pegg, A. Ornithine decarboxylase as an enzyme target for therapy. Pharmacol. Ther. 54, 195-215 (1992).
11. Van Daalen Wetters, T. Brabant, M. & Coffino, P. Regulation of ornithine decarboxylase activity by cell growth, serum and tetradecanoyl phorboi acetate is governed primarily by sequences within the coding region of the gene. Nucleic Acids Res. 17, 9843-9860 (1989).
12. Auvinen, M., Paasinen, A., Andersson, L.C. & Hölttä, E. Ornithine decarboxylase activity is critical for cell transformation. Nature 360, 355-358 (1992).
13. Luyengi, L. et al. Rotenoids and chalcones from Mundulea sericea with ornithine decarboxylase inhibiting activity. Phytochemistry 36, 1523-1526 (1994).
14. Verma, A.K. Inhibition of tumour promoter 12-O-tetradecanoylphorbol- 13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumour formation by retinoic acid. Cancer Res. 48, 2168-2173 (1988).
15. Verma, A.K., Pong, R.-C. & Erickson, D. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumour promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 46, 6149-6155 (1986).
16. Konoshima, T. et al. Studies on inhibitors of skin tumour promotion, XII. Rotenoids from Amorpha fruticosa. J. Nat. Prod. 56, 843-848 (1993).
17. O'Brien, R.D. Rotenoids. Insecticides. Action and Metabolism 159-163 (Academic Press, New York, 1967).
18. Fukami, H. & Nakajima, M. Rotenone and rotenoids. Naturally Occurring Insecticides 71-97 (Dekker, New York, 1971).
19. Burgos, J. & Redfearn, E.R. The inhibition of mitochondrial reduced nicotinamide-adenine dinucleotide oxidation by rotenoids. Biochim. bio- phys. Acta 110, 475-483 (1965).
20. Marshall, L.E. & Himes, R.H. Rotenone inhibition of tubulin self-assembly. Biochim. biophys. Acta 543, 590-594 (1978).
21. Anzeveno, P.B. Rotenoid Interconversion. Synthesis of deguelin from rotenone. J. org. Chem. 44, 2578-2580 (1979).
22. O'Brien, T.G. The induction of ornithine decarboxylase as an early, possibly obligatory event in mouse skin carcinogenesis. Cancer Res. 36, 2644-2653 (1976).
23. Lu, Y.-P., Chang, R.L., Huang, M.-T. & Conney, A.H. Inhibitory effect of curcumin on 12-0-tetradecanoyIphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis 14, 293-297 (1993).
24. Wagner, A.J., Meyers, C., Laimins, L.A. & Hay, N. c-Mγc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4, 879-883 (1993).
25. Bello-Fernandez, C. & Cleveland, J.L. C-mγc transactivates the ornithine decarboxylase gene. Curr. Topics Microbiol. Immunol. 182, 445-452 (1992).
26. Kakar, S.S. & Roy, D. Curcumin inhibits TPA-induced expression of c-fos, c-jun and c-mγc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett. 87, 85-89 (1994).
27. Lichti, U. & Gottesman, M.M. Genetic evidence that a phorboi ester tumor promoter stimulates ornithine decarboxylase activity by a pathway that is independent of cyclic AMP-dependent protein kinases in CHO cells.J. Cell Physiol. 113, 433-439 (1982).
28. Lowry, O.H., Rosebrough, N.J., Farr, A.L., & Randall, R.J. Protein measurement with the folin phenol reagent. J. biol. Chem. 193, 265-275 (1951).
29. Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
30. Kroczek, R.A. & Siebert, E. Optimization of northern analysis by vacuum- blotting, RNA-transfer visualization, and ultraviolet fixation. Anal. Biochem., 184, 90-95 (1990).
31. De Vries, D.J., Herald, C.L., Pettit, G.R. & Blumberg, P.M. Demonstration of sub-nanomolar affinity of bryostatin 1 for the phorboi ester receptor in rat brain. Biochem. Pharmacol. 37, 4069-4073 (1988).
32. Da Silva, C., Fan, X., Martelly, I. & Castagna, M. Phorboi ester mediated phospholipid-free activation of rat brain protein kinase C. Cancer Res. 50, 2081-2087 (1990).
33. Chen, I.-S. et al. Chemical and bioactive constituents from Zanthoxylum simulans. J. Nat. Prod. 54, 1206-1211 (1994).
34. McCormick, D.L. & Moon, R.C. Antipromotional activity of dietary N-(4- hydroxyphenyl)retinamide in two-stage skin tumourigenesis in CD-I and Senear mice. Cancer Lett. 31, 133-138 (1986).
35. Mehta, R, G., Steele, V., Kelloff, G J. & Moon, R.C. Influence of thiols and inhibitors of prostaglandin biosynthesis on the carcinogen-induced development of mammary lesions in vitro. Anticancer Res. 11, 587-592 (1991).